Aqueous solutions comprising pred- nislone and cyclodextrin derivative.

Details for Australian Patent Application No. 2005237421 (hide)

Owner Allergan, Inc.

Inventors Chang-Lin, Joan-En; Olejnik, Orest; Chang, James; Lyons, Robert T.; Chang, Chin-Ming

Agent Davies Collison Cave

Pub. Number AU-A-2005237421

PCT Pub. Number WO2005/105067

Priority 10/826,843 15.04.04 US

Filing date 11 April 2005

Wipo publication date 10 November 2005

International Classifications

A61K 31/00 (2006.01)

A61K 31/724 (2006.01)

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105067 Priority application(s): WO2005/105067

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237428-Novel imidazoles

2005237411-Orally disintegrating tablets and methods of manufacture